ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2025 ANS Winter Conference & Expo
November 9–12, 2025
Washington, DC|Washington Hilton
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Oct 2025
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
November 2025
Nuclear Technology
October 2025
Fusion Science and Technology
Latest News
Radiant to build first microreactor at Tenn. Manhattan Project site
Radiant Industries will build its first portable nuclear reactor at the site of the Manhattan Project in Oak Ridge, Tenn.
The land for Radiant’s new factory includes portions of the K-27 and K-29 Manhattan Project sites. The company plans to test Kaleidos, a 1-MW nuclear microreactor, in 2026, with first deployments expected soon after.
Xinwu Su, Yinlu Han
Nuclear Science and Engineering | Volume 193 | Number 7 | July 2019 | Pages 760-775
Technical Paper | doi.org/10.1080/00295639.2018.1560775
Articles are hosted by Taylor and Francis Online.
The neutron reaction data of 181Ta for the incident energy up to 200 MeV are urgently required for the study of nuclear reactor systems of fission or fusion. To meet this requirement, all cross sections, angular distributions, energy spectra, and double-differential cross sections for n + 180m,181Ta reactions are consistently calculated and analyzed at incident neutron energies up to 200 MeV. The theoretical results are compared with the experimental data and the evaluated results in ENDF/B-VIII, JENDL-4, and JEFF-3.